Martina Valgiusti

1.8k total citations
55 papers, 896 citations indexed

About

Martina Valgiusti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Martina Valgiusti has authored 55 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 18 papers in Hepatology. Recurrent topics in Martina Valgiusti's work include Colorectal Cancer Treatments and Studies (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Lung Cancer Treatments and Mutations (10 papers). Martina Valgiusti is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Lung Cancer Treatments and Mutations (10 papers). Martina Valgiusti collaborates with scholars based in Italy, France and South Korea. Martina Valgiusti's co-authors include Paola Ulivi, Alessandro Passardi, Giovanni Luca Frassineti, Matteo Canale, Andrea Casadei‐Gardini, Giorgia Marisi, Emanuela Scarpi, Giorgio Ercolani, Francesco Giuseppe Foschi and Dino Amadori and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Martina Valgiusti

52 papers receiving 884 citations

Peers

Countries citing papers authored by Martina Valgiusti

Since Specialization

Citations

This map shows the geographic impact of Martina Valgiusti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Valgiusti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Valgiusti more than expected).

Fields of papers citing papers by Martina Valgiusti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Valgiusti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Valgiusti. The network helps show where Martina Valgiusti may publish in the future.

Co-authorship network of co-authors of Martina Valgiusti

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Valgiusti. A scholar is included among the top collaborators of Martina Valgiusti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Valgiusti. Martina Valgiusti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial	JCO Precision Oncology	Elisabetta Petracci, Alessandro Passardi et al.	1
2	Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab	Therapeutic Advances in Medical Oncology	Alessandro Passardi, Alessandro Bittoni et al.	10
3	Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value	Molecular Therapy — Methods & Clinical Development	Ivan Vannini, Tania Rossi et al.	8
4	Conversion Surgery in Gastric Cancer Carcinomatosis	Frontiers in Oncology	Paolo Morgagni, Leonardo Solaini et al.	4
5	Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies	Biomolecules	Alessandro Passardi, Ilario Giovanni Rapposelli et al.	3
6	Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer	BMC Cancer	Ilario Giovanni Rapposelli, Valentina Zampiga et al.	4
7	Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis	Targeted Oncology	Changhoon Yoo, Sara Lonardi et al.	5
8	Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study	Cancers	Alessandro Passardi, Emanuela Scarpi et al.	9
9	<p>Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study</p>	Cancer Management and Research	Andrea Casadei‐Gardini, Emanuela Scarpi et al.	18
10	Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer	International Journal of Molecular Sciences	Paola Ulivi, Matteo Canale et al.	62
11	Radiofrequency Ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival	OncoTargets and Therapy	Andrea Casadei‐Gardini, Giorgia Marisi et al.	30
12	IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab	Cancer Management and Research	Giorgia Marisi, Emanuela Scarpi et al.	10
13	Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study	Radiation Oncology	Pierfrancesco Franco, Berardino De Bari et al.	16
14	Conversion surgery for gastric cancer: A cohort study from a western center	International Journal of Surgery	Paolo Morgagni, Leonardo Solaini et al.	52
15	Immune Checkpoints as a Target for Colorectal Cancer Treatment	International Journal of Molecular Sciences	Alessandro Passardi, Matteo Canale et al.	107
16	Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy	International Journal of Molecular Sciences	Paola Ulivi, Emanuela Scarpi et al.	39
17	Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study	Scientific Reports	Andrea Casadei‐Gardini, Flavia Foca et al.	28
18	Ang-2 polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib	Annals of Oncology	Giorgia Marisi, Alessandro Passardi et al.	1
19	Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab	Scientific Reports	Giorgia Marisi, Emanuela Scarpi et al.	24
20	Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib	Oncotarget	Andrea Casadei‐Gardini, Emanuela Scarpi et al.	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact